Patents by Inventor Yossi Dagon

Yossi Dagon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ALK7:ACTRIIB HETEROMULTIMERS AND USES THEREOF
    Publication number: 20160297867
    Abstract: In certain aspects, the disclosure provides soluble heteromeric polypeptide complexes comprising an extracellular domain of an ALK7 receptor and an extracellular domain of ActRIIB In certain aspects, these ALK7:ActRIIB heteromultimers are can be used to improve metabolic parameters in a patient in need thereof. In certain aspects, these ALK7:ActRIIB heteromultimers are can be used to treat or prevent one or more kidney-associated disease or condition in a patient in need thereof.
    Type: Application
    Filed: April 6, 2016
    Publication date: October 13, 2016
    Inventors: Ravindra Kumar, Asya Grinberg, Dianne Sako, Robert Scott Pearsall, Roselyne Castonguay, Gang Li, Yossi Dagon
  • Compounds for improving nutritional status, cognition and survival
    Patent number: 9333240
    Abstract: The present invention concerns using a leptin protein, a variant fragment or mimic of a leptin protein, or an activator of the AMPK signal transduction pathway for preparing a medicament that can either be used to improve cognitive function or to treat treatment of undesirable manifestations of a nutritional stress condition and to prolong survival.
    Type: Grant
    Filed: September 14, 2006
    Date of Patent: May 10, 2016
    Assignee: YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD.
    Inventors: Elliot Berry, Yosefa Avraham, Yossi Dagon
  • TREATMENT OF HEPATIC ENCEPHALOPATHY AND LIVER CIRRHOSIS
    Publication number: 20110251290
    Abstract: The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
    Type: Application
    Filed: June 16, 2011
    Publication date: October 13, 2011
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem, Aristotle University of Thessaloniki, Hadasit Medical Research Services & Development Ltd.
    Inventors: Elliot BERRY, Yosefa Avraham, Raphael Mechoulam, Yaron Ilan, Yossi Dagon, Iddo Magen, Nicholas Grigoriadis, Theofilos Poutachidis
  • Treatment of hepatic encephalopathy and liver cirrhosis
    Publication number: 20100022631
    Abstract: The compounds D9-tetrahydrocannabinol (THC), cannabidiol (CBD) and capsaicin are useful for prevention, treatment, or both, of hepatic encephalopathy. The compounds capsaicin, 2-arachidonoylglycerol (2-AG), HU-308 and cannabidiol are useful for prevention, treatment, or both, of liver cirrhosis.
    Type: Application
    Filed: April 24, 2009
    Publication date: January 28, 2010
    Applicants: Yissum Research Development Company of the Hebrew University of Jerusalem, Hadasit Medical Research Services & Development Ltd., Aristotle University of Thessaloniki
    Inventors: Elliot BERRY, Yosefa Avraham, Raphael Mechoulam, Yaron Ilan, Yossi Dagon, Iddo Magen, Nicholas Grigoriadis, Theofilos Poutachidis
  • Compounds for Improving Nutritional Status, Cognition and Survival
    Publication number: 20090175841
    Abstract: The present invention concerns using a leptin protein, a variant fragment or mimic of a leptin protein, or an activator of the AMPK signal transduction pathway for preparing a medicament that can either be used to improve cognitive function or to treat treatment of undesirable manifestations of a nutritional stress condition and to prolong survival.
    Type: Application
    Filed: September 14, 2006
    Publication date: July 9, 2009
    Inventors: Elliot Berry, Yosefa Avraham, Yossi Dagon
  • Methods of treating obesity and related disorders using tellurium selenium compounds
    Publication number: 20060166957
    Abstract: The present invention relates to methods of using tellurium and selenium containing compounds, and particularly to the use of small organic molecules containing tellurium or selenium as exemplified by the compound ammonium-trichloro(dioxoethylene-O,O?)tellurate (known by the abbreviation AS101) for treating obesity and obesity related disorders or complications and for reducing of food intake.
    Type: Application
    Filed: June 13, 2004
    Publication date: July 27, 2006
    Inventors: Menachem Rubinstein, Yossi Dagon, Benjamin Sredni, Michael Albeck